SOLVAZINC

This brand name is authorized in United Kingdom

Active ingredients

The drug SOLVAZINC contains one active pharmaceutical ingredient (API):

1 Zinc UNII PTX099XSF1 - ZINC SULFATE MONOHYDRATE

Zinc blocks the intestinal absorption of copper from the diet and the reabsorption of endogenously secreted copper. Zinc induces the production of metallothionein in the enterocyte, a protein that binds copper thereby preventing its transfer into the blood. The bound copper is then eliminated in the stool following desquamation of the intestinal cells. Read about Zinc

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SOLVAZINC Effervescent tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A12CB01	Zinc sulfate	A Alimentary tract and metabolism → A12 Mineral supplements → A12C Other mineral supplements → A12CB Zinc
Discover more medicines within A12CB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 36573